IXIARO®
ApprovedCompleted 0 views this week 0 watching💤 Quiet
Interest: 37/100
37
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Japanese Encephalitis
Conditions
Japanese Encephalitis
Trial Timeline
Jun 1, 2010 → Oct 1, 2011
NCT ID
NCT01158599About IXIARO®
IXIARO® is a approved stage product being developed by Valneva SE for Japanese Encephalitis. The current trial status is completed. This product is registered under clinical trial identifier NCT01158599. Target conditions include Japanese Encephalitis.
What happened to similar drugs?
2 of 20 similar drugs in Japanese Encephalitis were approved
Approved (2) Terminated (0) Active (18)
Hype Score Breakdown
Clinical
20
Activity
8
Company
9
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01158599 | Approved | Completed |
Competing Products
20 competing products in Japanese Encephalitis